Dr Duane Allen Lundeberg, MD | |
2222 Nw Lovejoy St, Suite #622, Portland, OR 97210-3033 | |
(503) 229-8455 | |
(503) 229-7028 |
Full Name | Dr Duane Allen Lundeberg |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 2222 Nw Lovejoy St, Portland, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063448728 | NPI | - | NPPES |
268284 | Medicaid | OR | |
26828-5 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD11457 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Duane Allen Lundeberg, MD 847 Ne 19th Ave, Suite 300, Portland, OR 97232-2684 Ph: (503) 963-2801 | Dr Duane Allen Lundeberg, MD 2222 Nw Lovejoy St, Suite #622, Portland, OR 97210-3033 Ph: (503) 229-8455 |
News Archive
Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types.
Mercury likely plays a role in the development of Alzheimer's disease, according to a review of relevant scientific literature published this month in The Journal of Alzheimer's Disease. Dr. Joachim Mutter of Germany, Dr. Richard Deth of the United States, and other esteemed researchers collaborated on the groundbreaking article Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism, which clarifies the need for continuing research to understand the cause of neurological diseases such as Alzheimer's.
Elbit Imaging Ltd. that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.
Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.
› Verified 2 days ago
David Wei Kuo Lin, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3600 N Interstate Ave, Interstate Medical Office Central, Portland, OR 97227 Phone: 503-331-6085 | |
Mr. Michael Lee Mcdonald, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10101 Se Main St, # 2004, Portland, OR 97216 Phone: 503-257-3204 Fax: 503-255-7208 | |
Brian Jacob Stater, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9155 Sw Barnes Rd Ste 536, Portland, OR 97225 Phone: 503-935-8100 Fax: 503-935-8110 | |
Dr. Edsel Uisuk Kim, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9155 Sw Barnes Rd Ste 536, Portland, OR 97225 Phone: 503-935-8100 Fax: 503-935-8110 | |
James Isaac Cohen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Ohsu Pv-01, Portland, OR 97239 Phone: 503-494-5355 Fax: 503-494-4631 | |
Dr. Larry Richard Thomas, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2222 Nw Lovejoy St, Suite #622, Portland, OR 97210 Phone: 503-229-8455 Fax: 503-229-7028 |